Description
The antimalarial injection Falcigo 60mg originates from Zydus Cadila with Artesunate as its active component and serves to treat severe and cerebral malaria in both adults and children. The antidisease properties of quinine-resistant malaria enable Falcigo 60mg to combat severe malaria infections.
Mechanism of Action
The active component in Falcigo 60mg selectively halts and blocks the multiplication of the plasmodium falciparum parasite. Artemisinin derivative artesunate releases free radicals during metabolism, which create destructive reactions to the parasite structure. Fast parasite removal followed by simplified malaria control becomes possible through this method.
Key Features
Manufacturer: Zydus Cadila
Active Ingredient: Artesunate 60mg
Dosage Form: Injection
Indications: Severe malaria, cerebral malaria, and quinine-resistant malaria
Benefits of Falcigo 60mg
- Facilitating the rapid diminution of the density of the parasites in the bloodstream
- Used in circumstances where quinine treatment proves to be ineffective
- Safe for both adults and children in severe malaria cases
Possible Side Effects
Some individuals may experience:
- Nausea
- Dizziness
- Low blood pressure
- Anemia
- Temporary liver enzyme elevation
Conclusion
Falcigo 60mg is available as an effective antimalarial injection for the treatment of severe malaria regardless of the type of malaria including those caused by the drug-resistant strains. Owing to its rapid onset of action and proven effectiveness, it forms an essential component of managing urgent and emergency care medical treatments. It may have health risks, always consult your doctor before taking this medicine.
Reviews
There are no reviews yet.